Equities

Angle PLC

AGL:LSE

Angle PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)8.00
  • Today's Change0.25 / 3.23%
  • Shares traded266.47k
  • 1 Year change-35.90%
  • Beta1.0040
Data delayed at least 20 minutes, as of Nov 04 2024 15:07 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments163232
Total Receivables, Net2.573.715.17
Total Inventory1.682.061.75
Prepaid expenses0.750.960.61
Other current assets, total------
Total current assets213939
Property, plant & equipment, net7.238.484.38
Goodwill, net2.212.212.21
Intangibles, net0.530.561.37
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets315047
LIABILITIES
Accounts payable1.061.501.12
Accrued expenses1.642.433.23
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.650.660.52
Other current liabilities, total0.600.660.04
Total current liabilities3.945.254.91
Total long term debt3.914.341.82
Total debt4.555.002.34
Deferred income tax------
Minority interest------
Other liabilities, total0.400.220.26
Total liabilities8.249.816.99
SHAREHOLDERS EQUITY
Common stock262624
Additional paid-in capital11611699
Retained earnings (accumulated deficit)(114)(96)(79)
Treasury stock - common(0.1)(0.1)(0.1)
Unrealized gain (loss)------
Other equity, total(4.87)(5.98)(3.96)
Total equity234040
Total liabilities & shareholders' equity315047
Total common shares outstanding261261236
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.